Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
博士 === 國防醫學院 === 醫學科學研究所 === 99 === Rationale: Non-small cell lung cancers carrying epidermal growth factor receptor (EGFR) mutations respond well to EGFR tyrosine kinase inhibitors (TKIs), but patients ultimately develop drug resistance and relapse. Although epithelial-mesenchymal transition (EMT)...
Main Authors: | TZU-HUA CHANG, 張慈華 |
---|---|
Other Authors: | CHIN-PYNG WU |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/01807552049649278825 |
Similar Items
-
Acquired and Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
by: Shang-Gin Wu, et al.
Published: (2016) -
Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor
by: Zhang Lingling, et al.
Published: (2016-01-01) -
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01) -
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
by: Tatsuya Nagano, et al.
Published: (2018-11-01) -
IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer
by: Shang-Gin Wu, et al.
Published: (2019-01-01)